Patents by Inventor Porino Jinjo VA

Porino Jinjo VA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109904
    Abstract: Described herein are tricyclic PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
    Type: Application
    Filed: September 20, 2023
    Publication date: April 4, 2024
    Inventors: Robert L. HOFFMAN, Porino Jinjo VA, Joseph Robert PINCHMAN, Qing DONG, Stephen W. KALDOR
  • Patent number: 11939329
    Abstract: Described herein are PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
    Type: Grant
    Filed: January 20, 2023
    Date of Patent: March 26, 2024
    Assignee: XinThera, Inc.
    Inventors: Robert L. Hoffman, Porino Jinjo Va, Joseph Robert Pinchman, Lynnie Trzoss, Qing Dong, Stephen W. Kaldor
  • Publication number: 20230348473
    Abstract: Described herein are tricyclic PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
    Type: Application
    Filed: April 27, 2023
    Publication date: November 2, 2023
    Inventors: Robert L. HOFFMAN, Porino Jinjo VA, Joseph Robert PINCHMAN, Qing DONG, Stephen W. KALDOR
  • Patent number: 11802128
    Abstract: Described herein are azetidine and pyrrolidine PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors.
    Type: Grant
    Filed: February 28, 2023
    Date of Patent: October 31, 2023
    Assignee: Xinthera, Inc.
    Inventors: Robert L. Hoffman, Qing Dong, Stephen W. Kaldor, Lynnie Trzoss, Porino Jinjo Va
  • Patent number: 11795173
    Abstract: Described herein are tricyclic PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors.
    Type: Grant
    Filed: April 27, 2023
    Date of Patent: October 24, 2023
    Assignee: Xinthera, Inc.
    Inventors: Robert L Hoffman, Porino Jinjo Va, Joseph Robert Pinchman, Qing Dong, Stephen W. Kaldor
  • Publication number: 20230234952
    Abstract: Described herein are PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
    Type: Application
    Filed: January 20, 2023
    Publication date: July 27, 2023
    Inventors: Robert L. HOFFMAN, Porino Jinjo VA, Joseph Robert PINCHMAN, Lynnie TRZOSS, Qing DONG, Stephen W. KALDOR
  • Publication number: 20230203033
    Abstract: Described herein are azetidine and pyrrolidine PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
    Type: Application
    Filed: February 28, 2023
    Publication date: June 29, 2023
    Inventors: Robert L. HOFFMAN, Qing DONG, Stephen W. KALDOR, Lynnie TRZOSS, Porino Jinjo VA
  • Publication number: 20230159525
    Abstract: Described herein are azetidine and pyrrolidine PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
    Type: Application
    Filed: September 30, 2022
    Publication date: May 25, 2023
    Inventors: Robert L. HOFFMAN, Qing DONG, Stephen W. KALDOR, Lynnie TRZOSS, Porino Jinjo VA
  • Publication number: 20230128041
    Abstract: Described herein are PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
    Type: Application
    Filed: September 19, 2022
    Publication date: April 27, 2023
    Inventors: Lynnie TRZOSS, Qing DONG, Stephen W. KALDOR, Robert L. HOFFMAN, Porino Jinjo VA, Joseph Robert PINCHMAN
  • Publication number: 20220348574
    Abstract: Described herein are PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
    Type: Application
    Filed: April 19, 2022
    Publication date: November 3, 2022
    Inventors: Lynnie TRZOSS, Qing DONG, Stephen W. KALDOR, Robert L. HOFFMAN, Porino Jinjo VA, Joseph Robert PINCHMAN